Citigroup’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,545
Closed -$295K 6157
2020
Q4
$295K Buy
3,545
+133
+4% +$9.69K ﹤0.01% 4676
2020
Q3
$158K Sell
3,412
-2,908
-46% -$276K ﹤0.01% 4779
2020
Q2
$779K Buy
6,320
+5,772
+1,053% +$657K ﹤0.01% 3816
2020
Q1
$58K Sell
548
-863
-61% -$154K ﹤0.01% 5841
2019
Q4
$364K Buy
1,411
+218
+18% +$81.3K ﹤0.01% 4700
2019
Q3
$629K Buy
1,193
+766
+179% +$567K ﹤0.01% 4123
2019
Q2
$402K Sell
427
-66
-13% -$66.3K ﹤0.01% 4636
2019
Q1
$535K Buy
+493
New +$441K ﹤0.01% 4114

Other funds holding ACB

Citigroup's ACB Position: Q1 2026 in Review

Citigroup reduced its Aurora Cannabis (ACB) stake by 72% in Q1 2026, selling an estimated $429K and leaving 43,523 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

Citigroup first reported a position in ACB in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.4M in Q2 2019. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Citigroup held 43,523 shares of Aurora Cannabis worth $143K as of Q1 2026.
  • Citigroup sold 113,497 Aurora Cannabis shares in Q1 2026, an estimated $429K.
  • Aurora Cannabis made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4142 holding.
  • Citigroup first reported a position in Aurora Cannabis in Q4 2018 and has held it in 24 quarters since.
  • Citigroup's Aurora Cannabis position peaked at $1.4M in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.